We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RSVR:NASDAQReservoir Media, Inc.. Analysis

Data as of 2026-04-29 - not real-time

$10.05

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Reservoir Media, Inc. is trading at $10.05, just above its 20‑day SMA of $9.95 and comfortably above the 200‑day SMA of $8.06, which the model flags as a bullish price trend. However, the MACD histogram is negative and the MACD line sits below its signal line, indicating short‑term bearish momentum despite the overall bullish direction. The RSI of 61 suggests the stock is not yet overbought, leaving some room for upside. Technical support sits near $9.46, while resistance is around $10.25, a level the price is approaching. Volume is decreasing, which could limit upward thrust. On the valuation side, the trailing P/E of 100.5 dwarfs the industry average of 18.7, and the DCF‑derived fair value of $3.33 is far below the market price, pointing to significant overvaluation. Forward earnings estimates improve the P/E to a more reasonable 14.6, but the gap between current and fair value remains large. Fundamentally, the company shows modest revenue growth (7.7%) and solid gross margins (64.5%), yet profit margins are thin (3.9%) and free cash flow is deeply negative at -$81M, reflecting cash burn. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 123 and total debt of $460M far exceeding cash reserves of $20.6M. Adding to the risk profile, a recent shareholder investigation by Kaskela Law introduces corporate‑governance concerns that could affect investor sentiment.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Negative MACD histogram signaling short‑term weakness
  • Decreasing volume reducing price momentum
  • Pending shareholder investigation increasing uncertainty

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Forward P/E of 14.6 suggesting earnings improvement
  • Potential upside to analyst target price of $13
  • Stable beta (0.8) indicating lower market volatility exposure

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Severe overvaluation relative to DCF fair value
  • High debt load and negative free cash flow
  • Corporate‑governance risk from ongoing shareholder probe

Key Metrics & Analysis

Financial Health

Revenue Growth7.70%
Profit Margin3.87%
P/E Ratio100.5
ROE1.76%
ROA2.60%
Debt/Equity122.80
P/B Ratio1.8
Op. Cash Flow$50.4M
Free Cash Flow$-81228224
Industry P/E18.7

Technical Analysis

TrendBullish
RSI61.4
Support$9.46
Resistance$10.25
MA 20$9.95
MA 50$9.42
MA 200$8.06
MACDBearish
VolumeDecreasing
Fear & Greed Index89.59

Valuation

Fair Value$3.33
Target Price$13.00
Upside/Downside29.35%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.80
Volatility21.97%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.